Vitamin D: The Iceberg Nutrient

被引:21
作者
Armas, Laura A. G. [1 ]
Heaney, Robert P. [1 ]
机构
[1] Creighton Univ, Med Ctr, Osteoporosis Res Ctr, Omaha, NE 68131 USA
关键词
SERUM PARATHYROID-HORMONE; CHRONIC KIDNEY-DISEASE; CANCER-MORTALITY; CALCIUM SUPPLEMENTATION; D DEFICIENCY; CHOLECALCIFEROL SUPPLEMENTATION; GEOGRAPHIC-VARIATION; RANDOMIZED-TRIAL; RISK; 25-HYDROXYVITAMIN-D;
D O I
10.1053/j.jrn.2010.09.002
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The understanding of vitamin D's role in human health has recently expanded. It is now recognized as more than a hormone activated in the kidney only for calcium homeostasis. It is metabolized and used by virtually every cell in the body. Patients with chronic kidney disease have a deficit in their kidney production of 1,25(OH)(2)D and have classically been treated with calcitriol or its active analogues. Despite often having lower systemic levels of 1,25(OH)(2)D, patients with chronic kidney disease retain the capability of extra renal production of 1,25(OH)(2)D. This has far reaching implications for their health. This review examines clinical trials and observations in 3 areas that impact chronic kidney disease patients. Cancer, cardiovascular disease and infections are responsible for much of the morbidity and mortality in this patient population. We will discuss vitamin D's role in these disease states with a focus on the chronic kidney disease patient. (C) 2011 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 64 条
  • [1] ALOIA JF, 2007, EPIDEMIOL INFECT, V134, P1129
  • [2] Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation
    Andress, DL
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (01) : 33 - 43
  • [3] [Anonymous], 2010, Am J kidney Diseases, V55, pS1, DOI DOI 10.1053/S0272-6386(10)00603-7
  • [4] Armas LA, 2009, INT J CLIN RHEUMATOL, V4, P89, DOI [10.2217/17584272.4.1.89, DOI 10.2217/17584272.4.1.89]
  • [5] Vitamin D2 is much less effective than vitamin D3 in humans
    Armas, LAG
    Hollis, BW
    Heaney, RP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11) : 5387 - 5391
  • [6] PRODUCTION OF 1,25-DIHYDROXYVITAMIN-D-3 BY PERFUSED PIG SKIN
    BIKLE, DD
    HALLORAN, BP
    RIVIERE, JE
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (05) : 796 - 798
  • [7] Positive association between 25-hydroxy, vitamin D levels and bone mineral density: A population-based study of younger and older adults
    Bischoff-Ferrari, HA
    Dietrich, T
    Orav, EJ
    Dawson-Hughes, B
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 116 (09) : 634 - 639
  • [8] Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752
  • [9] Effect of High-Dosage Cholecalciferol and Extended Physiotherapy on Complications After Hip Fracture A Randomized Controlled Trial
    Bischoff-Ferrari, Heike A.
    Dawson-Hughes, Bess
    Platz, Andreas
    Orav, Endel J.
    Staehelin, Hannes B.
    Willett, Walter C.
    Can, Uenal
    Egli, Andreas
    Mueller, Nicolas J.
    Looser, Silvan
    Bretscher, Beat
    Minder, Elisabeth
    Vergopoulos, Athanasios
    Theiler, Robert
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (09) : 813 - 820
  • [10] Chandra Prakash, 2008, Endocr Pract, V14, P10